In 2020, the global peripheral vascular device market size was valued at $11.9 billion, with over 16 million yearly peripheral vascular procedures performed. The market size is expected to increase at a compound annual growth rate (CAGR) of 5.2% to reach $16.9 billion in 2026. Throughout this medical market research, we analyzed 113 peripheral vascular

In 2020, the European peripheral vascular device market size was valued at about €1.3 billion, with over 1.15 million peripheral vascular procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 2.9% to reach €1.6 billion in 2026. Throughout this medical market research, we analyzed 65

In 2020, the U.S. peripheral vascular device market size was valued at $7.1 billion, with over 8.26 million peripheral vascular procedures performed each year. The market size is expected to increase and reach $10.4 billion by 2026. Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive

Thrombosis is defined as the formation of a blood clot inside a blood vessel, which obstructs the flow of blood. Thrombus can become life threatening if it dislodges from the vessel wall and enters the lungs or other vital organ. A fragment of thrombus traveling through the vascular system is called an embolus.

Lumen stenosis can occur due to the accumulation of thrombosis or plaque particles in a similar manner to peripheral arterial disease. The accumulation of these plaque particles has also been shown to cause calcification. Lumen stenosis is a considerable problem for both arteriovenous (AV) access surgical grafts and native fistulae because they have poor vessel patency. Due to their tendency to acquire blockages, AV access surgical grafts will require revascularization twice a year, and native fistulae will need to be cleared at least once a year.

The Chinese market for peripheral vascular devices includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices, stent grafts, surgical grafts, inferior vena cava filters, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths and vascular closure devices. Several of these devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those used for peripheral procedures are included in this report. As a result of a general increase in peripheral procedures and their relatively low cost, the market for PTA balloons will grow rapidly in China over the 2011–2018 forecast period.

The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, embolic protection devices, stent grafts, surgical grafts, IVUS catheters, inferior vena cava filters, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths and vascular closure devices. Several of these devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As a result of the general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as atherectomy devices is expected to grow rapidly in Japan over the 2011–2018 forecast period.